A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...
Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...
Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.
Several weight loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 ...
Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News ...
Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...
The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...
Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...
How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...
Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...
The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...